Breast Cancer

Experimental Genetic Screening Probe Finds Overlooked Microscopic Cancers

Published in Gene Therapy Weekly, October 27th, 1997

Scientists are developing a genetic screening method that may be 10 to 100 times more sensitive than routine pathological analysis of lymph nodes for microscopic evidence of breast cancer.

If further testing proves that the method can identify women in whom breast cancer most likely will recur, it could help cancer treatment specialists decide whether or not to institute aggressive anti-cancer therapy on affected patients.

The screening method uses a polymerase chain reaction (PCR) probe that signals the presence or absence of up to four genes that have been associated with breast cancer. When the PCR probe finds any one of the genes in DNA from...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1997-10-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry